for the Groupe Quest Est Leucemies Aigues Myeloblastiques (GOELAM). A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients - Witz, F; Sadoun, A; Perrin, MC (Blood, 1998)
et al.